Exenatide added to insulin glargine-treated patients with type 2 diabetes achieved glycemic targets and weight loss with no increased risk of hypoglycemia

Authors
Category Primary study
JournalDiabetes
Year 2010
This article has no abstract
Epistemonikos ID: afe13cee16208dbfdb84377ab24b3d99826c4dfa
First added on: Feb 06, 2025